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Abstract
Background: Since population screening has the potential to reduce mortality from rectal cancer (RC), novel methods 
with improved cost-effectiveness warrant consideration. In a previous pilot study, we found that the rapid, inexpensive 
and non-invasive electromagnetic detection of RC is a highly specific and sensitive technique. The aim of the present 
prospective study was to evaluate the prediction accuracy of electromagnetic detection of RC.
Methods: 304 eligible subjects were consecutively enrolled in our Institute and subjected to electromagnetic 
detection followed by colonoscopy and histopathologic analysis of biopsies. A putative RC carrier status was attributed 
to subjects showing an electromagnetic signal < 50 units (U).
Results: RC patients showed a significantly lower electromagnetic signal (40.9 ± 0.9 U; mean ± S.E.) than did non-RC 
subjects (79.2 ± 1.4 U; P < 2.2e-16). At a threshold < 50 U, electromagnetic detection identified 103 putative patients, 
whereas colonoscopy detected 108 patients, with an overlap of 91 patients between the two methods. The 15.7% 
false-negative rate by electromagnetic detection was brought to zero by raising the threshold value to 70 U; on the 
other hand, such a threshold increased the false-positive rate to 30%.
Conclusion: Electromagnetic detection of RC at a signal threshold < 70 U appears to eliminate false-negative results. 
Although colonoscopy would still be required in examining the false-positives associated with the < 70 U 
electromagnetic threshold, the need for this method would be reduced. Thus, electromagnetic detection represents a 
new accurate, rapid, simple, and inexpensive tool for early detection of RC that merits testing in large population-based 
programs.
Background
Population screening programs for the early diagnosis of
rectal cancer (RC) have the potential to reduce the inci-
dence and mortality from this disease. Most of these pro-
grams are based on stool tests or structural exams [1-3].
The main purpose of the screening should be to detect
90% of the sporadic cases of RC. In a health care system
with unlimited financial resources the choice of the type
of screening and the suitable population for this examina-
tion does not represent a problem. Everywhere, even
though there are different health care systems, financial
resources are limited and the rectal screening with the
current methods could be applied only to a selected pop-
ulation.
On the other hand, the majority of adults are not
receiving regular age- and risk-appropriate screenings or
have never been screened at all [4]. Despite the fact that
the primary barriers to screening are lack of health insur-
ance, lack of physician recommendation, and lack of
awareness of the importance of RC screening, the histori-
cal evidence shows that adults have different preferences
and patterns of use among the available RC screening
tests [5,6].
Thus, a less expensive, faster, and less invasive RC
screening procedure with a similar or better efficacy, as
compared to available methods, would provide a signifi-
cant advantage for RC prevention in the general popula-
tion. We recently carried out a pilot study for the
identification of RC by electromagnetic detection, a
method that is rapid, non-invasive, and inexpensive. As
compared to the results of colonoscopy, electromagnetic
detection of rectal cancer was highly specific (85%) and
highly sensitive (94%) [7]. Herein, by a prospective study
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442 patients have been admitted to our outpatient's
Department from January to August 2008 because of gas-
trointestinal disease or clinical symptoms related to col-
orectal risk. Exclusion criteria consisted of age younger
than 18 years, history of psychiatric illness, and preopera-
tive radiotherapy: 27 patients. Under written informed
consent, 415 subjects were recruited consecutively (10
patients refused the protocol). All subjects underwent
electromagnetic detection of RC, followed by colonos-
copy, The patients completed the examination with com-
puted tomography (positive colonoscopy) or abdominal
sonography (negative colonoscopy). The device lets the
examination limited to the pelvis and we regarded the
rectum cutoff within 15 cm from the anal verge. Biopsy of
suspected neoplastic lesions and histopathological exam
of the eventual lesions were performed (209 patients),
showing that 108 patients carried a rectal cancer whereas
101 patients carried a cancer in the upper gastrointestinal
tract (right or left colon); these latter patients were
excluded from this study (Table 1). The study protocol
was approved by the Institutional Review Board and Eth-
ics Committee of the Foundation IRCCS Istituto Nazion-
ale Tumori. The ClinicalTtrials.gov ID of the study is:
NCT00963794.
Electromagnetic detection of rectal cancer
RC screening was carried out using a Tissue Resonance
Interaction Method (TRIMprobe) electromagnetic detec-
tor (Galileo Avionica, Turin, Italy), which consists of a
nonlinear oscillator placed in a cylindrical probe about 30
cm long, a radiofrequency spectrum analyzer, and dedi-
cated computer software. Detection of RC is based on the
decrease of the electromagnetic signal compared to the
mean signal obtained in healthy subjects. The test was
performed while the patient stood 120 cm from the
receiver. The operator was on the opposite side of the
examined pelvis. No metallic objects were allowed on the
patient and no electronic devices were admitted in the
test area. The detector was kept at close contact to the
pelvis surface and was moved through six planes, to
obtain a scan of the whole pelvis volume. Based on our
previous study, we used the electromagnetic detection
system at 465 MHz frequency, in a scale from 0 to 255
arbitrary U [7]. Measurement of the electromagnetic sig-
nal was carried out in blind and before the colonoscopy
analysis.
Statistical analysis
Quantitative differences in electromagnetic score
between RC patients and non-RC subjects were analyzed
by the Kruskal-Wallis test. Correlations of the electro-
magnetic signal with size of neoplastic lesions or their
distance from anal verge were expressed as Spearman's
rho coefficient. Association between disease status and
electromagnetic signal scores was assessed using the
Table 1: Characteristics of controls and rectal adenocarcinoma patients subjected to electromagnetic and colonoscopy 
detections of rectal cancera
Subject characteristics Controls Cases
No. of subjects 196 108




Diameter of neoplastic lesion (mm) NAc 48.7 ± 1.7d
Distance from anal verge (cm)
2 - 6 NAc 47
7 - 10 NAc 33
11 - 15 NAc 27
Nodal status
N0 NAc 59
N ≥ 1 NAc 48
a Definition of RC cases and healthy controls based on the results of the colonoscopy; such exam has been carried out subsequently to the 
electromagnetic assay of rectal cancer. b Age in years. c NA, not applicable. d Mean ± SEVannelli et al. BMC Gastroenterology 2010, 10:45
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Fisher's exact test. Receiver operating characteristic
(ROC) curves were generated with ROCR package in R
Gui [8].
Results
This study of 442 subjects enrolled at our Institute due to
signs of RC risk was carried out using a blind and a pro-
spective design, with patients undergoing electromag-
netic detection followed by colonoscopy. Histopathologic
analysis of biopsies revealed that all RC cases were of the
adenocarcinoma histotype. Data from 196 patients with
negative colonoscopy results and 108 patients with rectal
cancer by colonoscopy were available for analysis. The
median patient age was 65 (range, 24-84) years for the
negative colonoscopy group and 65 (range, 22-85) years
for the positive colonoscopy group. All patients with a RC
diagnosis have been subjected to computed tomography,
which revealed 9 liver metastasis and no other primitive
cancer types. All patients with positive colonoscopy were
admitted to the hospital with a diagnosis of rectal adeno-
carcinoma and submitted to surgery.
Patients not carrying a RC, with the exception of 13
subjects, have been subjected to abdominal sonography,
which revealed no cancer pathology. However, 10
patients revealed active phlogistic processes: 6 inflamma-
tory bowel disease, 1 anal abscess and 3 fistulas. Since
PSA levels were not measured as a screening for prostate
cancer, this may be a possible limitation to the study
results.
Based on previous findings, we attributed a putative RC
carrier status to patients whose electromagnetic score at
465 MHz frequency was below 50 U, which identified 103
putative patients in our cohort (Table 2). Subsequent
colonoscopy to define RC patients (cases) and non-RC
subjects (controls) detected 108 patients (Table 1); the
overlap with electromagnetic detection was of 91 patients
(Table 2).
Mean age and gender distribution were similar between
cases and controls (Table 1). RC patients classified by
colonoscopy showed a significantly lower electromag-
netic signal than did non-RC subjects, i.e., 40.9 ± 0.9 U
(mean ± S.E.) versus 79.2 ± 1.4 U (p < 2.2e-16, Kruskal-
Wallis test; Fig. 1).
To evaluate the applicability of TRIMprobe electromag-
netic signal as a marker for distinguishing between RC
and non-RC disease groups, we performed ROC
(Receiver Operating Characteristic) curve analysis. ROC
curve showed the diagnostic ability of TRIMprobe elec-
tromagnetic signal in the differentiation of RC patients
versus non-cancer subjects (AUC = 0.96, 95% confidence
interval (CI) 0.94 - 0.98; P < 2.2e-16; Fig. 2A). In our
cohort, the sensitivity of the TRIMprobe device for RC
was 0.94, specificity was 0.84, negative predictive value
was 0.88, positive predictive value was 0.92, and accuracy
was 0.90 for the electromagnetic signal cutoff value of 50
U. Indeed, an electromagnetic signal < 50 U was signifi-
cantly associated with detection of RC by colonoscopy (p
< 2.2e-16, Table 2). Analysis of accuracy by cutoff value
indicated that ~50-55 U represent the best cutoff values
for detection of RC (Fig. 2B)
Since a major goal in screening tests is the minimiza-
tion of false-negative rates, we identified an electromag-
netic threshold, i.e., < 70 U, at which no RC was missed
(Table 2). However, at this threshold, 62 (31.6%) of the
non-RC subjects were false-positive (Table 2), whose dis-
ease or healthy status would have required clarification
by colonoscopy.
No association between nodal involvement (N0 versus
N ≥ 1) and the value of the electromagnetic signal was
observed. A significant inverse correlation was observed
between the size of the neoplastic lesions and the value of
the electromagnetic signal (Spearman's rho = -0.290, P =
0.002), whereas a significant positive correlation was
found between increasing distance from anal verge and
the value of the electromagnetic signal (Spearman's rho =
0.362, P = 0.0001).
Discussion
Since up to 10% of the general population might carry a
RC, depending on the age of the population undergoing
Table 2: Association between electromagnetic score settled out at different thresholds and the RC disease status defined 
by colonoscopy
Electromagnetic signal score Number of subjects with Pb
Non-RCa RCa
≥50 184 17
< 50 12 91 < 2.2e-16
≥70 134 0
< 70 62 108 < 2.2e-16
a By colonoscopy analysis. b Fisher's exact test.Vannelli et al. BMC Gastroenterology 2010, 10:45
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screening [2,9], new easy and non-expensive methods for
population screening for RC may be helpful for early
detection of such disease.
The most frequently used screening methods for RC
include two general categories: stool tests (tests for occult
blood or exfoliated DNA) and structural exams [endos-
copy, double-contrast barium enema and computed
tomographic colonography (CTC)]. The popular occult
blood test is characterized by simplicity, non-invasive-
ness, and demonstrated mortality benefit but suffers from
poor sensitivity, low population compliance, and high
costs of follow-up for false-positives. Indeed, in a large
study of asymptomatic patients who underwent occult
blood testing followed by endoscopy, the sensitivity of the
occult blood test for identifying advanced neoplasia was
only 24% [10]. Compared to the occult blood test, CTC is
much more expensive, whereas this technique has some
clear advantages when compared to endoscopy since it is
non-invasive, less time-intensive and is associated with a
lower risk of complications. However, CTC requires the
use of ionizing radiations, a high level of expertise in
reading, and has shown wide variations in sensitivity in
the various clinical trials [11].
Endoscopy is an invasive, lengthy and expensive proce-
dure requiring adequate clinical infrastructure and medi-
cal expertise, and is not without complications. Thus, it
represents even a relatively "poor screening" method for
RC at the general population level, especially as com-
pared with screening methods, such as the PAP test, for
other types of cancer. The ageing of the general popula-
tion in the Western world, with the consequent increase
of people at risk of RC, further makes large screening
programs based on colonoscopy unfeasible. Still, early
detection of RC can save lives [1,12] and can also
Figure 1 Lower electromagnetic signal associated with rectal 
cancer carrier status. Mean values of the electromagnetic signal (465 
MHz frequency), in arbitrary units, were statistically significant lower in 
RC cases than controls. Case and control categories were based on 
subsequent colonoscopy and histopathologic exam of biopsies. * P < 
2.2e-16, Kruskal-Wallis test.
Figure 2 Visualizations of TRIMprobe electromagnetic signal performance in detecting RC cancer. (A) ROC curve illustrating the high diagnos-
tic ability of TRIMprobe electromagnetic signal in the differentiation of RC patients versus non-cancer subjects, AUC = 0.96 (95% CI 0.94 - 0.98; P < 2.2e-
16). (B) Accuracy of the TRIMprobe electromagnetic signal in the differentiation of RC patients versus non-cancer subjects by the signal cutoff value. 
The best accuracy is obtained using cutoff values of ~50-55 U.Vannelli et al. BMC Gastroenterology 2010, 10:45
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decrease the cost of the patient's clinical management,
since patients with early neoplastic lesions require sim-
pler surgical resections and treatments than those with
advanced disease.
Although endoscopy is generally safe, it is still an inva-
sive procedure with several-fold higher rates of serious
complications than for any other commonly used cancer
screening test [13]. Repeated examinations over time may
incur a substantial cumulative rate of complications [14].
In addition, a relatively small risk (2 to 6%) of RC remains
6 to 36 months after negative colonoscopy, especially
when internists and family practice physicians rather
than gastroenterologists perform endoscopies [6].
However, in the near term, even greater incidence and
mortality reductions could be achieved if a greater pro-
portion of adults received regular screening [13].
Although prospective randomized trials and observa-
tional studies have demonstrated mortality reductions
associated with early detection of invasive disease, as well
as removal of adenomatous polyps, a majority of adults
are not receiving regular age and risk-appropriate screen-
ing or have never been screened at all [15].
Recent interest has focused on use of TRIMprobe for
diagnosis of disease as new screening strategy. This tech-
nique is characterized by simplicity, efficacy, and good
patient compliance.
In the present prospective study, patients with RC diag-
nosed by colonoscopy and histopathologic analysis
showed significantly lower values of the electromagnetic
signal as compared to non-RC patients (Fig. 1). At a signal
threshold of 50 U, defined by our previous study as the
optimal threshold in discriminating RC from non-RC
patients [7], the electromagnetic detection showed a
highly significant association with the RC status (Table 2,
Figs. 1, 2), thus confirming in an independent cohort our
previous findings.
This technology has also been investigated on other
cancers, in particular prostate cancers with favorable out-
comes [16,17].
The observed inverse correlation between the size of
the neoplastic lesions and the value of the electromag-
netic signal is consistent with the association between
low electromagnetic signal values and high probability of
RC, and raises the possibility that RC size represents a
factor affecting the sensitivity of RC electromagnetic
detection. The positive correlation observed between
increasing distance from anal verge and the value of the
electromagnetic signal may reflect a decreasing detection
power of the device with distance of the lesion or, alterna-
tively , with interference of anatomical structures in the
anal region. Further studies are needed to clarify the exis-
tence of a dimensional threshold or of a minimal distance
from anal verge of RC to be detected by electromagnetic
signal.
Notwithstanding the highly significant association
between electromagnetic detection and RC status
observed using the 50 U signal threshold, the frequency
of false-negative results at this threshold was relatively
high (15.7%, Fig. 2) and, although much less than the fre-
quency of missing RCs by the fecal occult blood test, too
high for population-based RC screening [6,18]. By
increasing the signal threshold value to 70 U, we can
avoid all false-negative findings in our cohort, thus we
can correctly identified all RC cases but increased the fre-
quency of false-positives to about 30% of the non-RC
subjects. Thus, follow-up colonoscopy in real- and false-
positive subjects would be necessary to characterize the
subject's disease status. We are aware of the limitations of
our study, since the relatively small size of our series and
the consequent low detection power. Also, TRIMprobe
was never tested in a multicentric study for the detection
of RC and control subjects from general population, with-
out any gastrointestinal symptoms related to RC risk,
have not been tested. Other possible limitations that have
not been addressed in the present study include operator
dependence and the effects of other gastrointestinal dis-
eases.
Conclusions
Our present findings point to the promise of electromag-
netic detection as a simple, accurate, and inexpensive tool
for early detection of RC in cancer prevention programs
at the general population level. However, the present
results represent only a first step and studies in large
cohorts and in different populations are needed to fur-
ther compare the usefulness of this method with other
RC screening methods, especially colonoscopy.
In addition, the description of benefits is complicated
by different performance characteristics of the variants
tests. Moreover, test performances in research settings
and in clinical practice may vary. Therefore, we can image
in the future the possibility to support the common
screening tests with electromagnetic detection.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AV has full access to all of the data in the study and takes full responsibility for
the integrity of the data and for the accuracy of the data analysis. AV and EL
conceived of and designed the study and drafted the manuscript. LB and EP
were responsible for data acquisition and critically revised the manuscript. EL
obtained funding. All authors have read and approved the final manuscript.
Acknowledgements
We thank TRIMprobe S.p.A. for providing the TRIMprobe TM device. The study 
was funded by intramural fundings.
Author Details
Division of General Surgery B, Fondazione IRCCS Istituto Nazionale Tumori, 
Milan, ItalyVannelli et al. BMC Gastroenterology 2010, 10:45
http://www.biomedcentral.com/1471-230X/10/45
Page 6 of 6
References
1. Schoellhammer HF, Gregorian AC, Sarkisyan GG, Petrie BA: How 
important is rigid proctosigmoidoscopy in localizing rectal cancer?  Am 
J Surg 2008, 196(6):904-8. discussion 908.
2. Tweedle EM, Rooney PS, Watson AJ: Screening for rectal cancer: will it 
improve cure rates?  Clin Oncol (R Coll Radiol) 2007, 19(9):639-648.
3. Lieberman DA, Weiss DG: One-time screening for colorectal cancer with 
combined fecal occult-blood testing and examination of the distal 
colon.  N Engl J Med 2001, 345:555-560.
4. Zampino MG, Labianca R, Beretta GD, Magni E, Gatta G, Leonardi MC, 
Chiappa A, Biffi R, de Braud F, Wils J: Rectal cancer.  Crit Rev Oncol Hematol 
2009, 70(2):160-182.
5. Lance P: Colorectal cancer screening: confusion reigns.  Cancer 
Epidemiol Biomarkers Prev 2008, 17(9):2205-2207.
6. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L: Rates of 
new or missed colorectal cancers after colonoscopy and their risk 
factors: a population-based analysis.  Gastroenterology 2007, 132:96-102.
7. Vannelli A, Leo E, Battaglia L, Poiasina E: Diagnosis of rectal cancer by 
electromagnetic interactions: preliminary results.  Dis Colon Rectum 
2009, 52:162-166.
8. Sing T, Sander O, Beerenwinkel N, Lengauer T: ROCR: visualizing classifier 
performance in R.  Bioinformatics 2005, 21(20):3940-3941.
9. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M: Randomized study 
of biennial screening with a faecal occult blood test: results after nine 
screening rounds.  Scand J Gastroenterol 2004, 39:846-851.
10. Heiken JP: Screening for colon cancer.  Cancer Imaging 2006, 6:S13-S21.
11. Arnesen RB, Adamsen S, Svendsen LB, Raaschou HO, von Benzon E, 
Hansen OH: Missed lesions and false-positive findings on computed-
tomographic colonography: a controlled prospective analysis.  
Endoscopy 2005, 37:937-944.
12. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L: 
Association of colonoscopy and death from colorectal cancer.  Ann 
Intern Med 2009, 150:1-8.
13. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK: 
Procedural success and complications of large-scale screening 
colonoscopy.  Gastrointest Endosc 2002, 55:307-314.
14. Ransohoff DF: Colon cancer screening in 2005: status and challenges.  
Gastroenterology 2005, 128:1685-1695.
15. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash 
C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, 
Rex DK, Smith RA, Thorson A, Winawer SJ, American Cancer Society 
Colorectal Cancer Advisory Group, US Multi-Society Task Force, American 
College of Radiology Colon Cancer Committee: Screening and 
surveillance for the early detection of colorectal cancer and 
adenomatous polyps, 2008: a joint guideline from the American 
Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, 
and the American College of Radiology.  Gastroenterology 2008, 
134(5):1570-1595.
16. Gokce O, Sanli O, Salmaslioglu A, Tunaci A, Ozsoy C, Ozcan F: Tissue 
Resonance Interaction Method (TRIMprob) has the potential to be 
used alongside the recognized tests in the screening protocols for 
prostate cancer.  Int J Urol 2009, 16(6):580-583.
17. Tubaro A, De Nunzio C, Trucchi A, Stoppacciaro A, Miano L: The 
electromagnetic detection of prostatic cancer: evaluation of 
diagnostic accuracy.  Urology 2008, 72(2):340-344.
18. Hosokawa O, Hattori M, Douden K, Hayashi H, Ohta K, Kaizaki Y: Difference 
in accuracy between gastroscopy and colonoscopy for detection of 
cancer.  Hepatogastroenterology 2007, 54:442-444.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-230X/10/45/prepub
doi: 10.1186/1471-230X-10-45
Cite this article as: Vannelli et al., Diagnosis of rectal cancer by Tissue Reso-
nance Interaction Method BMC Gastroenterology 2010, 10:45
Received: 16 October 2009 Accepted: 12 May 2010 
Published: 12 May 2010
This article is available from: http://www.biomedcentral.com/1471-230X/10/45 © 2010 Vannelli et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Gastroenterology 2010, 10:45